CDT

CDT Equity Inc. NASDAQ Listed Mar 28, 2022

Healthcare ·Biotechnology ·US · conduitpharma.com

$0.52

Pre-mkt $0.52 -1.13%

Mkt Cap $2.5M

52w Low $0.51 0.0% of range 52w High $586.00

50d MA $1.44 200d MA $37.84

P/E (TTM) 0.1x

EV/EBITDA 11.4x

P/B 0.0x

Debt/Equity 1.0x

ROE 547.1%

P/FCF -0.0x

RSI (14) 44.70

ATR (14) $0.23

Beta 2.08

50d MA $1.44

200d MA $37.84

Avg Volume 14.4M

CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

SIC Code

2834

CIK (SEC)

1896212

Phone

646 491 9132

4581 Tamiami Trail North · Naples, FL 34103 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 30, 2026	AMC	—	1.31	—	2.33	-1.3%	-3.0%	-7.1%	-1.0%	+8.7%	-8.0%	—
Apr 3, 2026	AMC	—	-99.99	—	—	—	—	—	—	—	—	—
Nov 13, 2025	AMC	—	-13.16	—	57.75	-8.2%	-3.5%	-1.7%	-4.6%	-16.7%	-4.6%	—
Aug 14, 2025	AMC	—	-43.68	—	334.00	+0.6%	-1.8%	-4.3%	-3.2%	+2.0%	-0.6%	—
May 15, 2025	AMC	—	-158.32	—	1224.00	-7.5%	-4.4%	-2.6%	+0.9%	-17.9%	-12.9%	—
Mar 28, 2025	AMC	—	-2438.38	—	2670.00	+12.4%	-12.2%	-7.5%	+3.4%	-8.2%	-5.8%	—
Nov 14, 2024	AMC	—	-839.58	—	28170.28	-6.3%	-9.1%	+7.6%	+0.2%	+0.2%	+16.9%	—
Aug 12, 2024	AMC	—	-839.58	—	51000.51	+0.0%	-19.1%	+8.1%	+6.5%	+0.6%	-0.7%	—
May 14, 2024	AMC	—	-0.05	—	852008.50	+3.2%	+4.6%	-1.0%	+1.0%	-2.0%	+3.1%	—
Apr 1, 2024	AMC	—	0.90	—	—	—	—	—	—	—	—	—
Nov 20, 2023	AMC	—	1.59	—	384003.84	+2.3%	+1.6%	+38.5%	+2.2%	+23.9%	+29.4%	—
Aug 15, 2023	AMC	—	-47.86	—	—	—	—	—	—	—	—	—

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
Jun 18, 2026	Taylor Mark Andrew10%	—	Sell	593,289	$1.40	$829K	—	-5.22%	-2.23%
Jun 18, 2026	Taylor Mark Andrew10%	—	Sell	1,464,711	$1.44	$2.1M	—	-5.22%	-2.23%
Jun 18, 2026	Taylor Mark Andrew10%	—	Sell	5,000	$0.71	$4K	1,464,711	-5.22%	-2.23%

Data updated apr 25, 2026 12:34am · Source: financialmodelingprep.com